Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use

Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Pharmaceutics and Biopharmaceutics - Volume 104, July 2016, Pages 226-234

Eva J. ter Weele, Anton G.T. Terwisscha van Scheltinga, Matthijs D. Linssen, Wouter B. Nagengast, Ingo Lindner, Annelies Jorritsma-Smit, Elisabeth G.E. de Vries, Jos G.W. Kosterink, Marjolijn N. Lub-de Hooge,